Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Birgitte Volck
Age : 59
Public asset : 39,852 USD
Country of residence : Unknown
Linked companies : Ascendis Pharma A/S - Nykode Therapeutics AS - Soleno Therapeutics, Inc.

Biography of Birgitte Volck 
Currently, Birgitte Volck holds the position of SVP, Head-Clinical Development & Medical Affairs at Ascendis Pharma A. Dr. Volck is also on the board of Soleno Therapeutics, Inc. and Vaccibody AS. Dr. Volck previously occupied the position of Head-Research & Development at GlaxoSmithKline Plc, Chief Medical Officer & Senior VP-Development at Swedish Orphan Biovitrum AB, President-Research & Development at Avrobio, Inc., Director-Executive Development at Amgen, Inc., Director-Nordic Medical & Project Director at Genzyme Danmark and Head-Clinical Development & Medical Affairs at Pharmexa A. Birgitte Volck received a doctorate from the University of Copenhagen.


Current positions of Birgitte Volck 
Holdings of Birgitte Volck 
Birgitte Volck : Personal Network 
Most Read News 
03/17EU countries to sign agreement to buy shells for Ukraine
RE
03/10Cathie Wood's ARK Fund set for worst week since Sept as higher rates loom
RE
03/20Ralph Hamers, the Dutchman thrust in the driver's seat at Swiss bank UBS
RE
04:00aMusk denies report on SpaceX's plans for new funding from Saudi, UAE
RE
03/16Branson's Virgin Orbit to pause operations, shares tumble
RE
03/15BlackRock CEO Fink warns of financial risks, persistent inflation
RE
03/10Fridman, Aven in talks over selling stake in Russia's Alfa Bank - paper
RE
03/21UBS set for talks with Michael Klein to terminate Credit Suisse investment bank deal - FT
RE
03/15Icahn urges Illumina to unwind Grail deal, pushes ahead on proxy fight
RE
03/23Elon Musk, WHO spar on Twitter over U.N. agency's role
RE
More news


© 2023 People and Ownership :   
Birgitte Volck : Connections 


Latest news about Birgitte Volck 
2022Transcript : Ascendis Pharma A/S - Special Call
CI
2022Transcript : Ascendis Pharma A/S, Q3 2022 Earnings Call, Nov 02, 2022
CI
2021Ascendis Pharma A/S Appoints Birgitte Volck as the Senior Vice President & Head of Clinical Development & Medical Affairs, Endocrinology Rare Diseases and Resigns from the Nominating and Corporate Governance Committee of the Company’S Board of Directors and Board of Directors
CI
2021Transcript : Soleno Therapeutics, Inc. - Shareholder/Analyst Call
CI
2020Soleno Therapeutics, Inc. Announces Executive Changes
CI
2020Transcript : AVROBIO, Inc. Presents at 16th Annual WORLDSymposium 2020, Feb-10-2020 through Feb-13-2020
CI
2020AVROBIO Announces Clinical Data Presentation and Multiple Events at WORLDSymposiumÖ 2020
CI
More news

Secure and increase the performance of your investments with our team of experts at your side.
Securing my Investments
fermer